Pulse Biosciences
PLSE
51 hedge funds and large institutions have $30.3M invested in Pulse Biosciences in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 6 reducing their positions, and 4 closing their positions.
350% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 6
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
94% more capital invested
Capital invested by funds: $15.6M → $30.3M (+$14.7M)
9% more funds holding
Funds holding: 47 → 51 (+4)
1.05% more ownership
Funds ownership: 10.61% → 11.66% (+1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.46M |
| 2 |
BlackRock
New York
|
+$1.31M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$938K |
| 4 |
Squarepoint
New York
|
+$390K |
| 5 |
State Street
Boston,
Massachusetts
|
+$374K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$90K |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$28K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$23.3K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$20.3K |
| 5 |
Citigroup
New York
|
-$12.4K |
PLSE Hedge Fund Activity: Q2 2020 in Review
51 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q2 2020, worth a combined $30.3M — up 94% from $15.6M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new PLSE positions and 4 closed out — a net gain of 4 holders — while 27 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.46M. The largest seller was Citadel Advisors, exiting entirely with an estimated $90K sold.
- 51 institutional investors held Pulse Biosciences (PLSE) as of Q2 2020, up from 47 in Q1 2020.
- Funds reported $30.3M of Pulse Biosciences stock for Q2 2020, up 94% quarter-over-quarter.
- 8 funds opened new Pulse Biosciences positions in Q2 2020 and 4 closed out, a net change of +4 holders.
- The largest Pulse Biosciences buyer in Q2 2020 was Vanguard Group, an estimated $1.46M added.
- The largest Pulse Biosciences seller in Q2 2020 was Citadel Advisors, an estimated $90K sold.
Based on aggregated 13F filings for Q2 2020.